CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer.

CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer. — المؤلف: Porcelli, Letizia — Cancers Mar 2019

المؤلف
Porcelli, Letizia
النشر
Cancers Mar 2019